Literature DB >> 15327425

Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane.

Siska Mortier1, Dirk Faict, Casper G Schalkwijk, Norbert H Lameire, An S De Vriese.   

Abstract

BACKGROUND: Chronic exposure to peritoneal dialysis fluid (PDF) affects the peritoneum, but precise causative factors are incompletely understood. We examined the effects of standard and new PDF on peritoneal function and structure.
METHODS: Female Wistar rats received twice daily intraperitoneal infusions of a standard lactate-buffered 3.86% glucose PDF at pH 5.5 (Dianeal) (N= 12), a low glucose degradation product (GDP) containing bicarbonate/lactate-buffered 3.86% glucose PDF at pH 7.4 (Physioneal) (N= 12), a lactate-buffered amino acid-based PDF at pH 6.7 (Nutrineal) (N= 12) or Earle's Balanced Salt Solution at pH 7.4 (EBSS) (N= 12) during 12 weeks.
RESULTS: Net ultrafiltration was lower after treatment with standard PDF, but not with low-GDP bicarbonate/lactate-buffered and amino acid-based PDF, compared to EBSS. Peritonea exposed to standard PDF were characterized by an increased expression of vascular endothelial growth factor (VEGF), microvascular proliferation as well as submesothelial fibrosis, which were not observed in other groups. Staining for methylglyoxal adducts was prominent in the standard PDF-exposed group, mild in the low GDP bicarbonate/lactate-buffered group and absent in the other groups. Standard PDF induced accumulation of advanced glycation end products (AGEs) and up-regulation of the receptor for AGE (RAGE). AGEs accumulation was absent and RAGE expression was only modestly increased in low-GDP bicarbonate/lactate-buffered and amino acid-based PDF.
CONCLUSION: Long-term in vivo exposure to standard PDF adversely affects peritoneal function and structure. A low-GDP bicarbonate/lactate-buffered and amino acid-based PDF better preserved peritoneal integrity and may thus improve the longevity of the peritoneal membrane. GDPs and associated accelerated AGE formation are the main causative factors in PDF-induced peritoneal damage.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15327425     DOI: 10.1111/j.1523-1755.2004.00879.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  52 in total

1.  Trials (and tribulations) of biocompatible peritoneal dialysis fluids.

Authors:  David W Johnson; Yeoungjee Cho; Fiona G Brown
Journal:  Perit Dial Int       Date:  2012 May-Jun       Impact factor: 1.756

Review 2.  Protecting the peritoneal membrane: factors beyond peritoneal dialysis solutions.

Authors:  Anneleen Pletinck; Raymond Vanholder; Nic Veys; Wim Van Biesen
Journal:  Nat Rev Nephrol       Date:  2012-07-10       Impact factor: 28.314

3.  Fluid dwell impact induces peritoneal fibrosis in the peritoneal cavity reconstructed in vitro.

Authors:  Shigehisa Aoki; Mitsuru Noguchi; Toshiaki Takezawa; Satoshi Ikeda; Kazuyoshi Uchihashi; Hiroyuki Kuroyama; Tomoyuki Chimuro; Shuji Toda
Journal:  J Artif Organs       Date:  2015-08-30       Impact factor: 1.731

4.  Advanced glycation end products, aortic stiffness, and wave reflection in peritoneal dialysis as compared to hemodialysis.

Authors:  Fabrice Mac-Way; Véronique Couture; Mihai S Utescu; Sophie Ignace; Sacha A De Serres; Renée-Claude Loignon; Karine Marquis; Richard Larivière; Mohsen Agharazii
Journal:  Int Urol Nephrol       Date:  2013-11-17       Impact factor: 2.370

5.  Dynamic O-linked N-acetylglucosamine modification of proteins affects stress responses and survival of mesothelial cells exposed to peritoneal dialysis fluids.

Authors:  Rebecca Herzog; Thorsten O Bender; Andreas Vychytil; Katarzyna Bialas; Christoph Aufricht; Klaus Kratochwill
Journal:  J Am Soc Nephrol       Date:  2014-05-22       Impact factor: 10.121

6.  Impact of a low-glucose peritoneal dialysis regimen on fibrosis and inflammation biomarkers.

Authors:  Susan Yung; Sing Leung Lui; Chris K F Ng; Andrew Yim; Maggie K M Ma; Kin Yee Lo; Chik Cheung Chow; Kwok Hong Chu; Wai Leung Chak; Man Fai Lam; Chun Yu Yung; Terence P S Yip; Sunny Wong; Colin S O Tang; Flora S K Ng; Tak Mao Chan
Journal:  Perit Dial Int       Date:  2015 Mar-Apr       Impact factor: 1.756

7.  Is It Beneficial to Convert to a Neutral-pH Bicarbonate/Lactate-Buffered PD Solution in Long-Term CAPD Patients? A Single-Center Prospective Study.

Authors:  Tae-Hyun Yoo; Mi Jung Lee; Hyung Jung Oh; Jung Tak Park; Seung Hyeok Han; Shin-Wook Kang; Dae Suk Han
Journal:  Perit Dial Int       Date:  2015 May-Jun       Impact factor: 1.756

8.  Biocompatible Dialysis Solutions Preserve Peritoneal Mesothelial Cell and Vessel Wall Integrity. A Case-Control Study on Human Biopsies.

Authors:  Gloria del Peso; José Antonio Jiménez-Heffernan; Rafael Selgas; César Remón; Marta Ossorio; Antonio Fernández-Perpén; José Antonio Sánchez-Tomero; Antonio Cirugeda; Erika de Sousa; Pilar Sandoval; Raquel Díaz; Manuel López-Cabrera; María Auxiliadora Bajo
Journal:  Perit Dial Int       Date:  2015-10-16       Impact factor: 1.756

9.  Hydration Status of Patients Dialyzed with Biocompatible Peritoneal Dialysis Fluids.

Authors:  Monika Lichodziejewska-Niemierko; Michał Chmielewski; Maria Dudziak; Alicja Ryta; Bolesław Rutkowski
Journal:  Perit Dial Int       Date:  2015-10-16       Impact factor: 1.756

10.  Preventive effect of Notch signaling inhibition by a gamma-secretase inhibitor on peritoneal dialysis fluid-induced peritoneal fibrosis in rats.

Authors:  Fengxin Zhu; Tang Li; Fanghua Qiu; Jinjin Fan; Qin Zhou; Xuebing Ding; Jing Nie; Xueqing Yu
Journal:  Am J Pathol       Date:  2010-01-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.